状态的急性氨酸诱导脑病变:基于注册表的评估
Valentin Loser1, Jan Novy1, Isabelle Beuchat1
1Department of Clinical Neurosciences, Service of Neurology, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland.
CNS drugs
|July 19, 2023
概括
酸诱导的脑病变 (VIE) 发生在10%的成年 status epilepticus (SE) 患者中,通常没有超血症. 临床警对于早期检测和在疑似VIE病例中撤销瓦尔酸盐至关重要.
科学领域:
- 神经学 神经学
- 临床药理学 临床药理学
背景情况:
- 酸诱导的脑病变 (VIE) 影响0.1-2.5%的患者.
- 成年 status epilepticus (SE) 的VIE的频率和特征是未知的.
研究的目的:
- 在成年SE患者中描述VIE的频率和临床生物学特征.
主要方法:
- 审查了39名成年SE患者接受了氨酸治疗 (2021年11月至2023年2月).
- 定义的急性VIE是因为在服用瓦尔酸盐后意识恶化,在停止治疗后96小时内消失.
- 分析了临床和生物数据,包括氨水平.
主要成果:
- 四名患者 (10%) 符合急性VIE标准.
- 到VIE发作和解决的中位时间为2天.
- 三名VIE患者缺乏高氨血症;在VIE病例中,肝病史更为频繁.
结论:
- 在 SE 中的 VIE 似乎相对频繁且不可预测.
- 对VIE症状的临床警是必不可少的,即使没有高氨血.
- 在怀疑VIE病例时,应考虑停止服用瓦尔酸盐.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
465
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
465
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
347
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
347
Antiepileptic Drugs: Potassium Channel Activators
215
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
215
Antiepileptic Drugs: Glutamate Antagonists
426
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
426
Seizures: Classification
424
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
424
Antiepileptic Drugs: Calcium Channel Blockers
462
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
462


